Aim-To examine the expression of HLA-ABC and HLA-DR major histocompatibility (MHC) antigens and intercellular adhesion molecule (ICAM)-l in normal, inflamed, metaplastic, and neoplastic oesophageal tissue and in freshly disaggregated tumours. Methods-Sequential sections of frozen tissue and cytospins of freshly disaggregated tumour were stained using the ABC peroxidase system and monoclonal antibodies specific for HLA-ABC, HLA-DR and ICAM-1. Results-Normal oesophageal tissue showed positive staining for HLA-ABC in the basal layers ofthe oesophageal squamous epithelium and on the epithelial cells of the submucosal oesophageal glands. HLA-DR and ICAM-1 were not detected in either of these cell types. In 20 of 37 (54%) carcinomas HLA-ABC was expressed weakly, with heterogeneous expression in nine (24%). Two tumours showed strong expression ofHLA-ABC, but 15 of37 (41%) were negative. HLA-DR and ICAM-1 were expressed weakly in six of 37 (16%) carcinomas without correlation with each other or with the expression ofHLA-ABC. Conclusions-HLA-ABC is absent from a high proportion of oesophageal carcinomas (41%) and is otherwise variably and weakly expressed with strong expression in only a small fraction (3%). In other carcinomas there is a higher level of HLA-ABC expression. This discrepancy may partly explain the aggressive nature of oesophageal carcinomas. HLA-DR and ICAM-1 are not normally expressed on those cells from which oesophageal carcinomas are thought to arise. The limited expression found here could suggest a partial or inhibited immune response against oesophageal carcinoma. In vivo repressive factors may be involved. (J Clin Pathol 1995;48:539-544) 
a high proportion of oesophageal carcinomas (41%) and is otherwise variably and weakly expressed with strong expression in only a small fraction (3%). In other carcinomas there is a higher level of HLA-ABC expression. This discrepancy may partly explain the aggressive nature of oesophageal carcinomas. HLA-DR and ICAM-1 are not normally expressed on those cells from which oesophageal carcinomas are thought to arise. The limited expression found here could suggest a partial or inhibited immune response against oesophageal carcinoma. In vivo repressive factors may be involved. An important factor which may affect the capacity of a tumour to elicit a cellular immune response is its expression of human leucocyte antigens (HLA) and intercellular adhesion molecule (ICAM)-1. These molecules may play an important role in regulating the progression ofmalignant growth. This is related to their central function in modulating the cellular immune response. Abnormal antigen expression by target cells is recognised by T cells in the context of HLA,' whilst ICAM-1 serves to modulate leucocyte adhesion and enhances immune recognition and target-effector interaction. 2 HLA-ABC, also called major histocompatibility complex (MHC) class I, antigens are expressed constitutively by most normal nucleated cells3 but may be lost in transformation to the neoplastic state."6 There is evidence that such a loss of expression can correlate significantly with a decreased degree of tumour differentiation-for example, in larynx,7 breast,8 lung,9 and basal cell carcinomas,'0 and also with a worse prognosis, at least in the case of laryngeal and breast carcinomas.
HLA In this study we examined for the first time the expression of MHC and ICAM-1 in tumours of 37 patients with oesophageal carcinoma and seven with adenocarcinomas of the gastric cardia. Three resected benign oesophagoi and five samples of Barrett's epithelium from tumour bearing oesophagoi were also investigated. Where possible the expression in tumour cells was compared with that of normal cells derived from the same resected specimen. taken. Similarly sized pieces of normal tissue were obtained from an area at least 5 cm away from any gross tumour. Samples were washed in medium before mincing. A single cell suspension was obtained by digesting overnight in 10 ml medium containing the enzymes collagenase (Boehringer Mannheim, Lewes, UK; 1 mg/ml), hyaluronidase (Boehringer Mannheim; 0-01 mg/ml) and DNase I (Boehringer Mannheim; 0-01 mg/ml). Any undigested clumps of tissue were removed and the remaining cell suspension washed twice in medium before being counted and assessed for viability using trypan blue exclusion staining. If the cells were sufficient in number and their viability exceeded 50%, they were used in further experiments. Duplicate samples of tumour and normal tissue were taken, snap frozen and stored in liquid nitrogen for immunohistochemical examination.
TISSUE AND CYTOSPIN PREPARATION Consecutive 7,um cryostat sections were fixed for 20 minutes in acetone at -200C and then stored at -800C until staining. Immediately after digestion of each tumour, cytospin preparations were made (using a Shandon Cytospin 3, Shandon Scientific, Runcorn, UK) with 5000 cells per slide. These were fixed in acetone for 20 minutes at -20'C and then stored at -80°C until staining.
IMMUNOHISTOCHEMICAL STAINING OF TISSUE SECTIONS AND CYTOSPINS
Endogenous peroxidase was inhibited in methanol containing 0-6% hydrogen peroxide for 12 minutes. The staining procedure accompanying the Vectastain "Elite" ABC kit (Vector Laboratories, Peterborough, UK) was followed. All of the primary antibodies were monoclonal mouse antihuman. The HLA-ABC (clone W6/32, isotype IgG2a), HIA-DR (clone CR3/43, isotype IgGI) and IgGl/IgG2a negative control antibodies were obtained from Dako (High Wycombe, UK). The ICAM-1 (clone 84H10, isotype IgG1) antibody was obtained from Serotec (Oxford, UK). 3,3'-Diaminobenzidine (DAB; Sigma, Poole, Dorset, UK) was used as chromogen. Parallel negative controls were performed using non-specific antibodies of IgGI/IgG2a isotypes. Parallel positive controls were performed using sections of tonsil. Sections were counterstained with Mayer's haematoxylin and mounted in DPX.
In reporting, cases were considered to be negative (less than 5% of cells stained), positive (more than 95% of cells stained), or heterogeneously positive (5-95% stained). The intensity of staining relative to internal stromal and inflammatory cells was also noted.
ROUTINE HISTOPATHOLOGICAL EXAMINATION
The tumours were classified for T, N and G according to the UICC system.2' Grade was reported according to the^most poorly differentiated area seen. Benign and Barrett' oesophagus All three resected benign strictures of the oesophagus had hyperplastic squamous epithelium and were highly inflamed. In one, with an intense lymphocytic and eosinophilic infiltrate of the lamina propria, the entire depth of the squamous epithelium (with the exception of the superficial squames) was strongly positive for HLA-ABC (fig 2) . The first three basal layers were positive for HLA-DR and the first basal layer was positive for ICAM-1. Another was also positive for HIA-ABC, although only through about half the depth of the epithelium. This sample was negative for HIA-DR but focally positive in the basal two layers for ICAM-1. The third case showed squamous staining identical with that seen in normal tissue.
Five specimens of adenocarcinoma included Barrett's oesophagus with intestinal metaplasia. In one of these there was carcinoma in situ whilst another showed moderate dysplasia. The remaining three were non-dysplastic, non-neoplastic. Both the carcinoma in situ and dysplastic cases were positive for HLA-ABC but negative for HLA-DR and ICAM-1. Two out of three non-dysplastic, non-neoplastic cases were positive for HLA class I. One of these was also positive for HIA-DR and one for ICAM-1. The third sample was negative for all three antigens. or more of the antigens. Most were alterations in the expression of a single antigen only: in three cases there was a higher percentage of malignant cells stained for HLA-ABC in the cytospins than in the original tumour section. Three cytospins stained for ICAM-1 also showed this pattern. In one sample there was reduction in the level of HLA-ABC expression. Four tumours showed changes in more than one antigen in cytospins compared with the original tumour sections. One of these showed an increase in HLA-ABC and -DR, one an increase in HLA-ABC and ICAM-1, and one an increase in HLA-DR but a decrease in ICAM-1 expression. The fourth sample showed increased expression of all three antigens.
Discussion
Much has been published about the HLA status of carcinomas such as lung, breast, larynx, colon, and cervix.24 However, similar studies in oesophageal carcinoma have not been carried out before. In this study we also stained normal stratified squamous oesophageal mucosa for HLA and ICAM-1 to compare the expression with that seen in oesophageal carcinoma.
Only four of 14 (29%) malignant tumours with a squamous component were homogeneously positive for HLA-ABC. This is surprising as squamous malignancies presumably arise from the dividing suprabasal layer of the epithelium, and this was found to be positive in normal tissue. Furthermore, two of three inflamed (benign) oesophagoi were shown to have enhanced expression of HLA-ABC. This indicates that squamous cells are able to respond to inflammatory cytokines.
Ten cases with non-neoplastic tissue containing submucosal oesophageal glands and five samples of Barrett's epithelium, the perceived premalignancy of oesophageal adenocarcinoma, were studied. All 10 normal glands were positive for HLA-ABC. Four offive (80%) ofthe Barrett's samples were positive, including the dysplastic and carcinoma in situ samples. However, only nine of 23 There are several possible implications from these observations of HLA-ABC in oesophageal carcinoma. The first is that the tumour clone(s) may have acquired a mutation which causes downregulation of HIA-ABC antigens. In vivo this would lead to fewer immune recognition molecules to stimulate a cytotoxic (CD8 +) T cell response. Alternatively, or additionally, the tumour cells may have become refractory to the effects of cytokines, such as interferon-'y, which are produced by leucocytes in an immune response and which normally upregulate HLA antigens. It is also possible that the tumour infiltrating lymphocytes (TIL) are not actually secreting such cytokines because there is repression of TIL activation in the local tumour environment. We are currently investigating this last possibility.
The low expression ofHILA-DR and ICAM-1 (only 16% of samples expressed one or both to some degree) by these tumours is perhaps not surprising if one considers that the cells of origin are normally negative for these antigens. There is evidence that some premalignant and benign lesions of epithelial tumours (breast, colon, cervix, larynx) acquire de novo expression of HLA-DR. 24 We did not find this in our limited study of Barrett's oesophagus, with only one offive (20%) samples proving positive. However, the limited expression of these molecules in oesophageal carcinoma is suggestive of cytokine induction from a partial immune response. The biological significance of the limited induction of these molecules is not yet known, but again could be related to suppression of infiltrating lymphocytes. Certainly, in other inflammatory conditions, such as graft versus host disease,'415 Crohn's disease,'3 ulcerative colitis,13 and coeliac disease,27 there is a pronounced induction of HLA-DR compared with the nonnal tissue. Indeed, two of three of the benign oesophagoi in this study stained positively for HLA-DRin the squamous epithelium, the only time this was observed. This is probably caused by chronic inflammation in such benign lesions where there are high concentrations of cytokine secreting lymphocytes and eosinophils.
ICAM-1 is expressed in malignant melan- antigens in vivo, but that the assembly and transportation of these antigens to the cell surface had been blocked by some suppressive agent. The presence ofsuch a suppressive factor could perhaps explain the cytoplasmic staining but lack ofmembranous staining in the majority of positive sections.
We are currently investigating the relation between inflammatory cell infiltrate and HLA/ ICAM-1 expression. Although this work is incomplete at this time, the results obtained to date suggest that there is no correlation between absolute numbers of total inflammatory, CD3 positive or interleukin-2 receptor positive cells and HLA/ICAM-1 status.
In conclusion, we have shown that a high proportion of oesophageal tumours show loss of HLA-ABC expression compared with the normal tissue from which they are derived and with most other carcinomas. We suggest that this may be important in the progression of this aggressive malignancy. We have also shown that there is limited expression of HLA-DR and ICAM-1 in this tumour and suggest that this represents a restricted immune response. In vivo local suppressive factors may lead to the inhibition of antigen expression.
